Literature DB >> 24210793

GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.

Lisa M Kosloski1, Elizabeth A Kosmacek, Katherine E Olson, R Lee Mosley, Howard E Gendelman.   

Abstract

Innate and adaptive immune responses can speed nigrostriatal neurodegeneration in Parkinson's disease (PD). We posit that GM-CSF can attenuate such responses. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxicated mice, GM-CSF given prior to MPTP protected nigral dopaminergic neurons coincident with altered microglial morphologies and regulatory T cell (Treg) induction. Adoptive transfer of GM-CSF-induced Treg to MPTP mice protected nigral neurons. Gene expression analyses revealed novel immune-based neuronal protection pathways linked to the upregulation of IL-27. The results provide evidence that GM-CSF modulation of immunity could be of clinical benefit for PD.
© 2013.

Entities:  

Keywords:  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Innate immunity; Neuroinflammation; Neuroprotection; Parkinson's disease; Regulatory T cells

Mesh:

Substances:

Year:  2013        PMID: 24210793      PMCID: PMC3872482          DOI: 10.1016/j.jneuroim.2013.10.009

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  66 in total

1.  Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.

Authors:  Ashley D Reynolds; Rebecca Banerjee; Jianou Liu; Howard E Gendelman; R Lee Mosley
Journal:  J Leukoc Biol       Date:  2007-08-03       Impact factor: 4.962

2.  Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.

Authors:  Ashley D Reynolds; Jason G Glanzer; Irena Kadiu; Mary Ricardo-Dukelow; Anathbandhu Chaudhuri; Pawel Ciborowski; Ronald Cerny; Benjamin Gelman; Mark P Thomas; R Lee Mosley; Howard E Gendelman
Journal:  J Neurochem       Date:  2007-11-22       Impact factor: 5.372

3.  Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury.

Authors:  H J Kim; J S Oh; S S An; W A Pennant; S-J Gwak; A N Kim; P K Han; D H Yoon; K N Kim; Y Ha
Journal:  Gene Ther       Date:  2011-10-20       Impact factor: 5.250

4.  Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1.

Authors:  Hong Liu; Christine Rohowsky-Kochan
Journal:  J Interferon Cytokine Res       Date:  2011-01-15       Impact factor: 2.607

5.  IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells.

Authors:  Caroline Diveu; Mandy J McGeachy; Katia Boniface; Jason S Stumhofer; Manjiri Sathe; Barbara Joyce-Shaikh; Yi Chen; Cristina M Tato; Terrill K McClanahan; René de Waal Malefyt; Christopher A Hunter; Daniel J Cua; Robert A Kastelein
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

6.  Glutathione peroxidase, glial cells and Parkinson's disease.

Authors:  P Damier; E C Hirsch; P Zhang; Y Agid; F Javoy-Agid
Journal:  Neuroscience       Date:  1993-01       Impact factor: 3.590

Review 7.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

Review 8.  Promoting transplantation tolerance; adoptive regulatory T cell therapy.

Authors:  N Safinia; J Leech; M Hernandez-Fuentes; R Lechler; G Lombardi
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

9.  The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions.

Authors:  Markus Krieger; Martin Both; Simon A Kranig; Claudia Pitzer; Matthias Klugmann; Gerhard Vogt; Andreas Draguhn; Armin Schneider
Journal:  Sci Rep       Date:  2012-09-26       Impact factor: 4.379

10.  Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.

Authors:  Joost Smolders; Mariëlle Thewissen; Evelyn Peelen; Paul Menheere; Jan Willem Cohen Tervaert; Jan Damoiseaux; Raymond Hupperts
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

View more
  45 in total

Review 1.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

2.  Lipopolysaccharide-Induced Microglia Activation Promotes the Survival of Midbrain Dopaminergic Neurons In Vitro.

Authors:  Xiaolai Zhou; Björn Spittau
Journal:  Neurotox Res       Date:  2017-11-29       Impact factor: 3.911

Review 3.  Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.

Authors:  Kristopher G Hooten; David R Beers; Weihua Zhao; Stanley H Appel
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

Review 4.  Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Authors:  Marina Romero-Ramos; Marianne von Euler Chelpin; Vanesa Sanchez-Guajardo
Journal:  Hum Vaccin Immunother       Date:  2014-03-26       Impact factor: 3.452

Review 5.  Microglial phenotypes in Parkinson's disease and animal models of the disease.

Authors:  Valerie Joers; Malú G Tansey; Giovanna Mulas; Anna R Carta
Journal:  Prog Neurobiol       Date:  2016-04-20       Impact factor: 11.685

Review 6.  Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.

Authors:  Katherine E Olson; Aditya N Bade; Charles R Schutt; Jingdong Dong; Scott J Shandler; Michael D Boska; R Lee Mosley; Howard E Gendelman; Yutong Liu
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

7.  Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice.

Authors:  Katherine E Olson; Aditya N Bade; Krista L Namminga; Mary Jane Potash; R Lee Mosley; Larisa Y Poluektova; David J Volsky; Howard E Gendelman
Journal:  J Neurovirol       Date:  2018-03-28       Impact factor: 2.643

8.  Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice.

Authors:  Tomomi Kiyota; Jatin Machhi; Yaman Lu; Bhagyalaxmi Dyavarshetty; Maryam Nemati; Izumi Yokoyama; R L Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2018-03-17       Impact factor: 3.478

9.  Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).

Authors:  Violeta Chitu; Solen Gokhan; Maria Gulinello; Craig A Branch; Madhuvati Patil; Ranu Basu; Corrina Stoddart; Mark F Mehler; E Richard Stanley
Journal:  Neurobiol Dis       Date:  2014-12-09       Impact factor: 5.996

Review 10.  Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.

Authors:  Katherine E Olson; Howard E Gendelman
Journal:  Curr Opin Pharmacol       Date:  2015-11-11       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.